Document Details
Form
Filing Date
Jun 14, 2024
Document Date
Jun 12, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
Galson Steven K